Can Kids Take Benzonatate? Age Limits and Safety Risks

Benzonatate is not approved for children under 10 years old, and for good reason: even a single capsule can kill a small child. The FDA has specifically warned that accidental ingestion by children younger than 10 carries an increased risk of death. For kids 10 and older, the drug is technically approved, but the evidence supporting its effectiveness is surprisingly thin, and the margin between a therapeutic dose and a dangerous one is narrow enough that many pediatricians avoid prescribing it to younger patients altogether.

The FDA’s Age Cutoff

Benzonatate (sold under the brand name Tessalon) has been on the market since 1958. It works by quieting the cough reflex, specifically by dampening stretch receptors in the lungs whose signals travel through the vagus nerve to the brain. It is chemically related to local anesthetics like tetracaine and procaine, which partly explains why overdoses are so dangerous: the drug can numb and disrupt the electrical activity of the heart and nervous system.¹

The FDA’s official labeling restricts the drug to patients over 10 years of age. In 2010, the agency issued a Drug Safety Communication reinforcing this restriction, warning that accidental ingestion by children younger than 10 has led to deaths and adding new information to the drug’s Warnings and Precautions label.² That safety communication, however, did not appear to reduce the rate of poisonings. A study evaluating the impact of the warning found that benzonatate exposures continued to climb afterward, with no meaningful change in the rate of severe outcomes.³

Why It Is Especially Lethal in Small Children

The scariest thing about benzonatate poisoning is how fast it moves. A systematic review of severe poisoning cases found that toxicity can set in within five minutes of ingestion.⁴ That leaves almost no window to intervene before a child is in crisis. An FDA analysis found that seizures, cardiac arrest, coma, and respiratory arrest occurred in some patients within 15 minutes of swallowing the drug.⁵

Small children face extra risk for a few reasons. First, benzonatate capsules come in soft gelatin “perles” that look like candy and are easy to chew. If a child bites into one, the liquid inside releases a concentrated dose of the drug almost immediately into the mouth and throat, numbing the tissues on contact and accelerating absorption. Second, body weight matters enormously. A standard 100 mg or 200 mg capsule represents a far higher dose per kilogram in a toddler than in an adult. Poison center data confirm that both reported fatalities in children aged zero to five involved unintentional ingestions.⁶

How Poisonings Actually Happen

The pattern of who gets poisoned depends heavily on age group. Data from U.S. poison control centers covering 2010 through 2018 logged nearly 4,700 pediatric benzonatate exposures. About 80 percent involved just benzonatate alone, and roughly three-quarters of all cases were unintentional. The overwhelming majority of those unintentional exposures, about 83 percent, involved children from birth to five years old.⁶ This is the classic scenario: a toddler finds a bottle in a parent’s or grandparent’s medicine cabinet, sees what looks like a small candy, and swallows one or more capsules.

An earlier review spanning 2000 to 2006 found that about 30 percent of all benzonatate ingestions reported to poison centers involved children under six. Among those with serious outcomes, including cases rated moderate, major, or fatal, roughly a third were in that same young age group.⁷ These numbers are striking given that benzonatate is not even indicated for young children. Every single one of these exposures in the under-10 group represents a drug reaching a child it was never meant for.

Teenagers and Intentional Misuse

The picture shifts significantly in older children. Among kids aged 10 to 16, intentional exposures rose over the study period, with a particular spike in cases involving multiple substances. Most benzonatate cases classified as misuse or abuse occurred in this age group, accounting for about 61 percent of all such cases in the pediatric data set.⁶ Because benzonatate is chemically related to local anesthetics, some teenagers appear to experiment with it for the numbing sensation it produces in the mouth and throat, sometimes combining it with other drugs.

Case reports illustrate how quickly intentional overdoses can spiral. One published case described a 14-year-old who swallowed 14 capsules of 200 mg benzonatate. She developed a dangerous heart rhythm called torsades de pointes and went into cardiac arrest. She was the only reported pediatric benzonatate overdose complicated by cardiac arrest who made a full recovery without lasting brain damage.⁸ That outcome was lucky. Another case report documented an overdose resulting in cardiac arrest, seizures, and permanent blindness.⁹

The message for parents of teenagers is different from the childproofing concern with toddlers. Teens who know benzonatate is in the house may seek it out deliberately. If your child is prescribed benzonatate for a legitimate cough and you have concerns about self-harm risk or substance experimentation, dispensing each dose yourself rather than leaving the bottle accessible is a reasonable precaution.

What Benzonatate Overdose Looks Like

Recognizing benzonatate toxicity quickly is critical because of how little time there is to respond. The signs tend to appear in a predictable cascade:

Mouth numbness: If the capsule was chewed, the lips, tongue, and throat go numb almost immediately. This alone can be dangerous in a small child, because loss of sensation in the throat increases the risk of choking or aspiration.
Tremors and restlessness: Agitation and shaking often appear within minutes as the drug hits the nervous system.
Seizures: Convulsions are one of the hallmark signs and can begin within minutes of ingestion.⁵
Heart rhythm problems: Dangerous arrhythmias, including the type that caused cardiac arrest in the 14-year-old case described above, can develop rapidly.
Respiratory arrest and coma: In the worst cases, breathing stops and the brain is deprived of oxygen, leading to coma or death.

If you suspect a child has swallowed even one benzonatate capsule, call 911 or Poison Control (1-800-222-1222 in the U.S.) immediately. Do not wait for symptoms. The rapid onset means a child who seems fine at the moment could be seizing five minutes later.

What Emergency Treatment Involves

There is no specific antidote for benzonatate poisoning. Treatment is supportive, meaning the medical team works to keep the patient alive while the drug clears the body. That typically includes securing the airway with intubation, managing seizures with standard anti-seizure medications, and monitoring the heart continuously for arrhythmias.¹⁰

One treatment approach that has shown promise in case reports is intravenous lipid emulsion therapy. Because benzonatate is fat-soluble, infusing a lipid solution into the bloodstream can help draw the drug out of tissues and slow its toxic effects, buying the body more time to compensate.¹⁰ In the case of the patient who survived with permanent blindness, the treatment included sedation, intubation, emergency stomach pumping, and a hypothermia protocol to protect the brain.⁹ These are extreme measures for what started with a cough medicine.

Does Benzonatate Even Work Well?

Here is something that often gets lost in the conversation about safety: the evidence that benzonatate works effectively as a cough suppressant is remarkably weak. A systematic review of all available literature on benzonatate’s safety and effectiveness found that the original clinical studies supporting its approval were small, poorly designed, and at high risk of bias. The review concluded that there is a substantial lack of quality evidence for benzonatate’s role in modern medical practice and called for large observational studies or randomized trials to properly evaluate it.¹¹

This is worth pausing on. A drug that has been prescribed for over 60 years, that can kill a toddler with a single capsule, has never been put through the kind of rigorous testing we now expect from a modern medication. It was approved in 1958 under standards that would not pass today. Many clinicians prescribe it simply because it has always been available, not because strong data show it outperforms alternatives. For parents weighing whether to push for a benzonatate prescription for their child’s cough, the honest answer is that safer options with better evidence exist.

Safer Alternatives for Children’s Coughs

Most childhood coughs are caused by viral upper respiratory infections and resolve on their own within a week or two. The American Academy of Pediatrics and other major pediatric organizations generally advise against cough suppressants in young children, because coughing serves a protective function by clearing mucus from the airways. But when a cough is severe enough to interfere with sleep and daily life, families understandably want relief.

Honey has the best evidence for children over one year old. A randomized trial comparing honey, dextromethorphan (the active ingredient in many over-the-counter cough syrups), and no treatment found that honey outperformed both. Parents rated their children’s cough frequency, severity, sleep quality, and overall bother as all improving more with honey than with dextromethorphan or no treatment. The combined symptom improvement score averaged about 10.7 points for honey versus 8.4 for dextromethorphan and 6.4 for no treatment.¹² A half to one teaspoon of honey before bed is a simple, safe remedy with real data behind it. The critical caveat is that honey should never be given to infants under one year old due to the risk of botulism.

Saline nasal irrigation is another option. A systematic review of studies in children with acute upper respiratory infections found that rinsing the nose with saline solution may reduce symptom severity and could speed recovery, though the authors noted that stronger studies are still needed to confirm the benefit.¹³ For children old enough to tolerate it, a simple saline rinse or spray can thin mucus and reduce the post-nasal drip that triggers coughing, especially at night.

Cool-mist humidifiers, adequate fluids, and elevating the head of the bed are also standard recommendations. None of these carry the life-threatening risks of benzonatate. For persistent or unusual coughs, such as those lasting more than three weeks, producing blood, or accompanied by high fever or breathing difficulty, a pediatrician visit is warranted to rule out causes that need targeted treatment rather than a cough suppressant.

Keeping Benzonatate Away From Children

If an adult in the household uses benzonatate, storage matters more than it does for most medications. The capsules are small, shiny, and soft enough that a toddler can easily mistake them for candy. Standard advice is to store the bottle in a locked cabinet or high shelf out of reach and sight of children, and to never transfer capsules to unlabeled containers, pill organizers, or purses where curious hands might find them.

Child-resistant packaging has historically been one of the most effective tools for preventing accidental poisonings. Research on the Poison Prevention Packaging Act found that the ingestion rate for substances requiring child-resistant closures dropped from about 5.7 per 1,000 children in 1973 to 3.4 per 1,000 by 1978, and the packaging was estimated to have prevented nearly 200,000 accidental ingestions in that period.¹⁴ But child-resistant does not mean childproof. Studies of packaging design have shown that strategies relying on hand size and grip strength work reasonably well against children aged three to six, while designs that depend on reading ability or complex operations are less consistently effective across different ages and developmental stages.¹⁵

A few practical measures that go beyond standard childproofing:

Count your capsules: Know how many are in the bottle so you can quickly tell if any are missing.
Take it privately: Avoid taking the medication in front of young children who might want to imitate you.
Educate older children: For households with teenagers, a frank conversation about the drug’s lethality is more useful than hoping they will not find it.
Dispose of extras: If you finish your course of treatment with capsules left over, take them to a pharmacy drug take-back program rather than leaving them in the medicine cabinet.

When a Doctor Prescribes Benzonatate for a Child Over 10

If your child is 10 or older and a doctor prescribes benzonatate, that falls within the drug’s labeled use. The standard dose is 100 mg or 200 mg taken up to three times daily. The capsules must be swallowed whole, never chewed or dissolved in the mouth, because releasing the liquid inside can numb the throat and potentially cause choking. Children who struggle to swallow pills reliably are poor candidates for this drug regardless of age.

It is also worth asking your prescriber whether benzonatate is truly necessary or whether a trial of simpler measures would be reasonable first. Given the systematic review’s finding that the evidence base for benzonatate’s effectiveness is weak, “it’s always been prescribed” is not, by itself, a compelling reason to choose a drug with a well-documented capacity to cause fatal poisoning if misused.¹¹ If a cough is genuinely severe enough to warrant prescription treatment, other options exist, and a conversation with the pediatrician about the relative risks and benefits is always appropriate.

The Rising Trend in Exposures

One troubling pattern in the data is that benzonatate prescribing and exposure rates have been climbing. A study examining over 18,000 benzonatate exposures reported to U.S. poison centers found a steady increase in cases over the study period. The FDA’s 2010 safety warning did not reverse this trend and produced no statistically significant drop in severe outcomes.³ This suggests that the warning reached prescribers and pharmacists unevenly, or that the underlying increase in prescriptions overwhelmed whatever protective effect the alert provided.

The growth in benzonatate prescribing is partly tied to the broader shift away from opioid-containing cough suppressants like codeine, which the FDA itself restricted in pediatric patients. Benzonatate filled that gap as a non-narcotic alternative. The irony is that a drug adopted in part because of safety concerns about opioids carries its own severe toxicity risk, especially in the very population the opioid restriction was designed to protect. As more households have benzonatate bottles on the shelf, the odds of accidental pediatric exposure continue to grow.